Gary K. Lee
CIK 1907345 · Chief Scientific Officer · last filed 2026-02-12
Gary K. Lee is a Chief Scientific Officer who has filed 11 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing shows the insider sold $39.1K of LYEL on Feb 12, 2026. Across all open-market trades the lifetime net is −$62.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $228.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$228.7K
1
11
-$62.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LYEL | Chief Scientific Officer | 16,938 | $13.50 | $228.7K | -$62.8K | 11 | 2026-02-12 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-12 | LYEL | Sell (S) | −1,671 | -$39.1K | EDGAR |
| 2026-02-11 | LYEL | Mixed | +3,853 | -$3.4K | EDGAR |
| 2025-11-12 | LYEL | Sell (S) | −138 | -$2.2K | EDGAR |
| 2025-10-29 | LYEL | Grant (A) | — | $0 | EDGAR |
| 2025-08-22 | LYEL | Mixed | +6,547 | -$15.3K | EDGAR |
| 2025-08-13 | LYEL | Sell (S) | −267 | -$2.8K | EDGAR |
| 2025-02-26 | LYEL | Grant (A) | +112,500 | $0 | EDGAR |
| 2024-02-13 | LYEL | Grant (A) | +40,000 | $0 | EDGAR |
| 2023-11-20 | LYEL | Mixed | — | $0 | EDGAR |
| 2023-02-28 | LYEL | Grant (A) | — | $0 | EDGAR |